{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:11:36Z","timestamp":1793293896870,"version":"4.5.0"},"reference-count":8,"publisher":"American Society of Hematology","issue":"12","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,6,28]]},"DOI":"10.1182\/bloodadvances.2021006922","type":"journal-article","created":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T14:08:36Z","timestamp":1646921316000},"page":"3606-3610","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":89,"title":["Real-world evidence of brexucabtagene autoleucel for the treatment of relapsed or refractory mantle cell lymphoma"],"prefix":"10.1182","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0805-9288","authenticated-orcid":false,"given":"Gloria","family":"Iacoboni","sequence":"first","affiliation":[{"name":"1Department of Hematology, Vall d\u2019Hebron University Hospital, Experimental Hematology, Vall d\u2019Hebron Institute of Oncology (VHIO), Barcelona, Spain;"},{"name":"2Department of Medicine, Universitat Aut\u00f2noma de Barcelona, Bellaterra, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Rejeski","sequence":"additional","affiliation":[{"name":"3Department of Medicine III, University Hospital, LMU Munich, Munich, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4868-6585","authenticated-orcid":false,"given":"Guillermo","family":"Villacampa","sequence":"additional","affiliation":[{"name":"4Oncology Data Science, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain;"},{"name":"5SOLTI Breast Cancer Research Group, Barcelona, Spain;"},{"name":"6The Institute of Cancer Research, London, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0214-3219","authenticated-orcid":false,"given":"Jaap A.","family":"van Doesum","sequence":"additional","affiliation":[{"name":"7Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2977-0098","authenticated-orcid":false,"given":"Annalisa","family":"Chiappella","sequence":"additional","affiliation":[{"name":"8Division of Hematology and Stem Cell Transplantation, Fondazione IRCCS Istituto Nazionale dei Tumori, University of Milano, Milano, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Bonifazi","sequence":"additional","affiliation":[{"name":"9IRCCS Azienda Ospedaliero-Universitaria di Bologna Istituto di Ematologia \u201cSer\u00e0gnoli\u201d, Bologna, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1908-5596","authenticated-orcid":false,"given":"Lucia","family":"Lopez-Corral","sequence":"additional","affiliation":[{"name":"10Hematology Department, Hospital Cl\u00ednico Universitario de Salamanca, IBSAL, CIBERONC, Salamanca, Spain;"},{"name":"11Centro de Investigaci\u00f3n del C\u00e1ncer-IBMCC, Salamanca, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiel","family":"van Aalderen","sequence":"additional","affiliation":[{"name":"12Department of Hematology, Amsterdam University Medical Centers, Cancer Center Amsterdam, LYMMCARE (Lymphoma and Myeloma Center Amsterdam), Amsterdam, The Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi","family":"Kwon","sequence":"additional","affiliation":[{"name":"13Department of Hematology, Hospital General Universitario Gregorio Mara\u00f1\u00f3n, Madrid, Spain;"},{"name":"14Gregorio Mara\u00f1\u00f3n Health Research Institute, Madrid, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuria","family":"Mart\u00ednez-Cibrian","sequence":"additional","affiliation":[{"name":"15Department of Hematology, Hospital Clinic, Barcelona, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Bramanti","sequence":"additional","affiliation":[{"name":"16Istituto Clinico Humanitas IRCCS, Rozzano, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Luis","family":"Reguera-Ortega","sequence":"additional","affiliation":[{"name":"17Department of Hematology, University Hospital Virgen del Rocio, Sevilla, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9609-0394","authenticated-orcid":false,"given":"Lina","family":"Camacho-Arteaga","sequence":"additional","affiliation":[{"name":"18Clinical Pharmacology Department, Vall d\u2019Hebron University Hospital, Barcelona, Spain;"},{"name":"19Clinical Pharmacology, Vall d\u2019Hebron Institut de Recerca, Vall d\u2019Hebron Hospital Universitari, Barcelona, Spain;"},{"name":"20Department of Pharmacology, Therapeutics and Toxicology, Autonomous University of Barcelona, Barcelona, Spain; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Schmidt","sequence":"additional","affiliation":[{"name":"3Department of Medicine III, University Hospital, LMU Munich, Munich, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Mar\u00edn-Niebla","sequence":"additional","affiliation":[{"name":"1Department of Hematology, Vall d\u2019Hebron University Hospital, Experimental Hematology, Vall d\u2019Hebron Institute of Oncology (VHIO), Barcelona, Spain;"},{"name":"2Department of Medicine, Universitat Aut\u00f2noma de Barcelona, Bellaterra, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie Jos\u00e9","family":"Kersten","sequence":"additional","affiliation":[{"name":"12Department of Hematology, Amsterdam University Medical Centers, Cancer Center Amsterdam, LYMMCARE (Lymphoma and Myeloma Center Amsterdam), Amsterdam, The Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6330-1028","authenticated-orcid":false,"given":"Alejandro","family":"Martin Garcia-Sancho","sequence":"additional","affiliation":[{"name":"10Hematology Department, Hospital Cl\u00ednico Universitario de Salamanca, IBSAL, CIBERONC, Salamanca, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2112-2651","authenticated-orcid":false,"given":"Pier Luigi","family":"Zinzani","sequence":"additional","affiliation":[{"name":"9IRCCS Azienda Ospedaliero-Universitaria di Bologna Istituto di Ematologia \u201cSer\u00e0gnoli\u201d, Bologna, Italy;"},{"name":"21Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale Universit\u00e0 di Bologna, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Corradini","sequence":"additional","affiliation":[{"name":"8Division of Hematology and Stem Cell Transplantation, Fondazione IRCCS Istituto Nazionale dei Tumori, University of Milano, Milano, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"van Meerten","sequence":"additional","affiliation":[{"name":"7Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3905-0251","authenticated-orcid":false,"given":"Marion","family":"Subklewe","sequence":"additional","affiliation":[{"name":"3Department of Medicine III, University Hospital, LMU Munich, Munich, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pere","family":"Barba","sequence":"additional","affiliation":[{"name":"1Department of Hematology, Vall d\u2019Hebron University Hospital, Experimental Hematology, Vall d\u2019Hebron Institute of Oncology (VHIO), Barcelona, Spain;"},{"name":"2Department of Medicine, Universitat Aut\u00f2noma de Barcelona, Bellaterra, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2022,6,20]]},"reference":[{"issue":"14","key":"2022062015231013200_B1","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1056\/NEJMoa1914347","article-title":"KTE-X19 CAR T-cell therapy in relapsed or refractory mantle-cell lymphoma","volume":"382","author":"Wang","year":"2020","journal-title":"N Engl J Med."},{"issue":"8","key":"2022062015231013200_B2","doi-asserted-by":"crossref","first-page":"E298","DOI":"10.1002\/ajh.26233","article-title":"Brexucabtagene autoleucel therapy induces complete remission in a primary refractory blastoid mantle cell lymphoma with neurolymphomatosis","volume":"96","author":"Khurana","year":"2021","journal-title":"Am J Hematol."},{"issue":"4","key":"2022062015231013200_B3","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.bbmt.2018.12.758","article-title":"ASTCT consensus grading for cytokine release syndrome and neurologic toxicity associated with immune effector cells","volume":"25","author":"Lee","year":"2019","journal-title":"Biol Blood Marrow Transplant."},{"issue":"27","key":"2022062015231013200_B4","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","article-title":"Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification","volume":"32","author":"Cheson","year":"2014","journal-title":"J Clin Oncol."},{"issue":"27","key":"2022062015231013200_B5","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1200\/JCO.19.02104","article-title":"Standard-of-care axicabtagene ciloleucel for relapsed or refractory large B-cell lymphoma: results from the US Lymphoma CAR T Consortium","volume":"38","author":"Nastoupil","year":"2020","journal-title":"J Clin Oncol."},{"issue":"27","key":"2022062015231013200_B6","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1200\/JCO.19.02103","article-title":"Axicabtagene ciloleucel in the non-trial setting: outcomes and correlates of response, resistance, and toxicity","volume":"38","author":"Jacobson","year":"2020","journal-title":"J Clin Oncol."},{"issue":"21","key":"2022062015231013200_B7","doi-asserted-by":"crossref","first-page":"5414","DOI":"10.1182\/bloodadvances.2020003092","article-title":"Real-world evidence of tisagenlecleucel for pediatric acute lymphoblastic leukemia and non-Hodgkin lymphoma","volume":"4","author":"Pasquini","year":"2020","journal-title":"Blood Adv."},{"issue":"10","key":"2022062015231013200_B8","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1002\/cam4.3881","article-title":"Real-world evidence of tisagenlecleucel for the treatment of relapsed or refractory large B-cell lymphoma","volume":"10","author":"Iacoboni","year":"2021","journal-title":"Cancer Med."}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/6\/12\/3606\/1902623\/advancesadv2021006922.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/6\/12\/3606\/1902623\/advancesadv2021006922.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,20]],"date-time":"2022-06-20T11:27:35Z","timestamp":1655724455000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/6\/12\/3606\/484368\/Real-world-evidence-of-brexucabtagene-autoleucel"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,20]]},"references-count":8,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,6,28]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2021006922","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,20]]}}}